UBS reiterates Buy on Celsius stock, cites penetration growth

UBS reiterated a Buy on Celsius Holdings with a $55 price target versus a $29.82 share price, citing continued household penetration, buy-rate growth, and shelf-space gains expected in 2026-2027. The firm acknowledged sequential slowdown since late December amid intensifying competition and weaker portfolio segments, but said the long-term trajectory remains strong. Recent Q1 2026 results also beat expectations, with EPS of $0.41 vs. $0.30 consensus and revenue of $783 million vs. $763.07 million, even though the stock sold off further.

Analysis

The key setup is not whether the brand is still growing, but whether the market is mispricing the slope of deceleration. A name like CELH can look cheap on near-term earnings momentum even as channel fill and mix normalize, which is usually when multiples compress fastest. The fact that sell-side support remains constructive while the tape keeps fading suggests investors are still anchoring to the growth-era narrative and have not fully discounted a prolonged re-rating phase.

Second-order, the real beneficiary is Pepsi, not because of direct EPS leverage, but because any shelf-space win in 2026/27 is effectively a negotiated expansion of one of the highest-velocity energy platforms in the channel. That raises the bar for smaller energy brands and private-label challengers that depend on incremental facings to maintain relevance. If Celsius keeps taking space without broad-based category growth accelerating, the spillover will likely be share loss elsewhere in the energy aisle rather than category expansion.

Near term, the stock looks vulnerable to a classic “good quarter, bad guide” pattern where beats are dismissed if the market believes the out-quarter setup is deteriorating. The risk window is days to weeks around any update that confirms slower velocity or tougher retailer inventory resets; the upside reversal case is a visible re-acceleration in household penetration or a strong launch cadence that proves innovation can offset maturity. Longer term, the consensus may be underestimating how much distribution leverage still exists if Pepsi’s shelf-space allocation algorithm continues to favor CELH, but that is a 2-4 quarter story, not an immediate catalyst.

From a technical standpoint, the proximity to lows means the stock can still overshoot fundamentals in either direction, so position sizing should reflect event-driven volatility rather than valuation alone. The market is likely pricing in a deterioration in growth quality more than a collapse in absolute demand, which creates room for a sharp squeeze only if the company surprises on sell-through, not just reported revenue.

Key Decisions for Investors

• Buy CELH only on confirmation of stabilization in weekly/channel checks; use a 4-8 week horizon and size for volatility, targeting a rebound toward prior range highs if the market starts pricing 2026 shelf-space gains earlier.
• Sell a downside put spread in CELH with 1-2 quarter expiry to express the view that the market has already priced in a good chunk of deceleration; cap risk below the 52-week low and monetize elevated implied volatility.
• Pair trade: long PEP / short CELH for 1-3 months if retailer checks suggest Celsius is winning space at the margin but losing pricing power and mix quality; Pepsi captures the lower-beta monetization of distribution.
• Avoid adding into any post-earnings strength unless management explicitly re-accelerates guidance commentary; the risk/reward is poor if the move is just short covering with no evidence of velocity inflection.
• For opportunistic traders, buy CELH call spreads only on a decisive reclaim of the 50-day trend with improving volume; this is a tactical squeeze trade, not a fundamental conviction long.